Nobody in the industry moves teeth like we do. By marrying Candid Rx™—our patent-pending approach to moving teeth—and CandidOS™—our ecosystem of hardware and software—we enable superior care and outcomes for patients. Welcome to the new orthodontics.
candidco.comThese are collections Candid is a part of. Click on the collection name to view similar companies.
Series B
$63,400,000
Convertible Note
$8,000,000
Series A
$15,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Candid.